Description
Both TREM2 and complement pathways were identified as key hypotheses but the molecular crosstalk between these systems remains undefined. This mechanistic gap prevents integrated therapeutic approaches targeting both pathways.
Source: Debate session sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402 (Analysis: SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:32.021801+00:00”, “resolution_summary”: “Resolved by hypothesis h-dffb42d9de: Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin. Supporting evidence includes debate sess_SDA-2026-04-11-gap-debate-20260410-112636-141592ba.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-dffb42d9de”, “title”: “Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin”, “score”: 0.232, “reason”: “12 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-06-gap-debate-20260406-062039-3b945972”, “target_gene”: “CHI3L1/TREM2/NRGN”, “target_pathway”: null, “disease”: “biomarkers”, “composite_score”: 0.756553, “confidence_score”: 0.68, “status”: “proposed”, “pubmed_evidence_ids”: [“29198979”, “30814620”, “32084334”, “32783918”, “33516818”]}, {“id”: “h-1eaa052225”, “title”: “Regional TREM2-Dependent Lipid Metabolism Determines Cortical Vulnerability in Alzheimer’s Disease”, “score”: 0.23, “reason”: “12 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041439-ec89b1e4”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.713763, “confidence_score”: 0.3, “status”: “proposed”, “pubmed_evidence_ids”: [“23529425”, “26763208”, “30664783”, “32302527”, “N/A”]}, {“id”: “h-trem2-fe8c644a”, “title”: “Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Phagocytosis from Inflammation”, “score”: 0.224, “reason”: “14 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-02-gap-001”, “target_gene”: “TREM2, ADAM10, ADAM17”, “target_pathway”: “ectodomain shedding, microglial survival signaling”, “disease”: “Alzheimer’s disease”, “composite_score”: 0.71429, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“27986010”, “29695715”, “33483491”, “41509917”]}, {“id”: “h-immunity-c64967ab”, “title”: “TREM2-APOE4 Axis Drives Metabolic Inflexibility in DAM”, “score”: 0.224, “reason”: “11 token overlaps; entity overlap: trem2”, “analysis_id”: null, “target_gene”: “TREM2, APOE4, LDHA”, “target_pathway”: null, “disease”: “Alzheimer’s disease”, “composite_score”: 0.708451, “confidence_score”: 0.72, “status”: “open”, “pubmed_evidence_ids”: [“28602351”, “28993883”, “29263254”, “29861287”, “33516818”]}, {“id”: “h-e27f712688”, “title”: “TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Restorative”, “score”: 0.223, “reason”: “11 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062118-2cdbb0dd”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “synaptic biology”, “composite_score”: 0.752658, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“25292920”, “31442935”, “31902528”, “33516818”, “36747024”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-11-gap-debate-20260410-112636-141592ba”, “title”: “The debate highlighted that TREM2 therapeutic targeting remains contested across disease stages, but no clear framework exists for when to activate versus inhibit TREM2 signaling. This timing question is critical for clinical translation but remains empirically unresolved.\n\nSource: Debate session sess_SDA-2026-04-02-gap-001 (Analysis: SDA-2026-04-02-gap-001)”, “score”: 0.561, “reason”: “9 token overlaps; entity overlap: sda-2026-04-02-, trem2”, “analysis_id”: “SDA-2026-04-11-gap-debate-20260410-112636-141592ba”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-debate-20260410-112522-57d1cc4f”, “title”: “While TREM2 was identified as critical for microglial senescence, the debate lacked fine-grained temporal data on when and how TREM2 signaling shifts from neuroprotective to pathogenic. Understanding this transition timing is essential for intervention strategies.\n\nSource: Debate session sess_SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402 (Analysis: SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402)”, “score”: 0.505, “reason”: “7 token overlaps; entity overlap: sda-2026-04-02-, trem2”, “analysis_id”: “SDA-2026-04-15-gap-debate-20260410-112522-57d1cc4f”, “quality_score”: 0.73, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402”, “title”: “Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states, T-cell infiltration. Anchor to existing TREM2 (h-b234254c, h-044ee057) and complement cascade hypotheses (h-58e4635a, h-1fe4ba9b, h-5a55aabc). Produce inflammatory pathway diagrams and generate 3-5 new hypotheses connecting immune findings to disease mechanisms.”, “score”: 0.447, “reason”: “6 token overlaps; entity overlap: sda-2026-04-02-, trem2”, “analysis_id”: “SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402”, “quality_score”: 0.55, “status”: “completed”, “target_artifact_id”: “SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402”, “target_artifact_type”: “analysis”}, {“id”: “sess_SDA-2026-04-11-gap-debate-20260410-112725-4369698d”, “title”: “The debate failed to produce any actual hypotheses despite this being the core research question. The methodological approach for integrating mouse aging transcriptomics with human neurodegeneration data remains undefined and represents a critical analytical gap.\n\nSource: Debate session sess_SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402 (Analysis: SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402)”, “score”: 0.435, “reason”: “8 token overlaps; entity overlap: sda-2026-04-02-”, “analysis_id”: “SDA-2026-04-11-gap-debate-20260410-112725-4369698d”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-02-gap-001”, “title”: “The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, but whether therapeutic agonism or antagonism of TREM2 is beneficial remains contested across disease stages.”, “score”: 0.423, “reason”: “4 token overlaps; entity overlap: sda-2026-04-02-, trem2”, “analysis_id”: “SDA-2026-04-02-gap-001”, “quality_score”: 0.89, “status”: “completed”, “target_artifact_id”: “SDA-2026-04-02-gap-001”, “target_artifact_type”: “analysis”}], “paper_matches”: []}